List of Tables
Table 1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Citalopram (Celexa)
Table 3. Key Players of Escitalopram (Lexapro)
Table 4. Key Players of Fluoxetine (Prozac)
Table 5. Key Players of Paroxetine (Paxil, Pexeva)
Table 6. Key Players of Sertraline (Zoloft)
Table 7. Key Players of Vilazodone (Viibryd)
Table 8. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region (2019-2024)
Table 12. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region (2025-2030)
Table 14. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Trends
Table 15. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Drivers
Table 16. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Challenges
Table 17. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Restraints
Table 18. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Players (2019-2024)
Table 20. Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) as of 2023)
Table 21. Ranking of Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Product Solution and Service
Table 25. Date of Enter into Selective Serotonin Reuptake Inhibitors (SSRIs) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2019-2024)
Table 29. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Type (2025-2030)
Table 31. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2019-2024)
Table 33. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application (2025-2030)
Table 35. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Country (2025-2030) & (US$ Million)
Table 50. Allergan Plc Company Detail
Table 51. Allergan Plc Business Overview
Table 52. Allergan Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 53. Allergan Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024) & (US$ Million)
Table 54. Allergan Plc Recent Development
Table 55. Eli Lilly and Co. Company Detail
Table 56. Eli Lilly and Co. Business Overview
Table 57. Eli Lilly and Co. Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 58. Eli Lilly and Co. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024) & (US$ Million)
Table 59. Eli Lilly and Co. Recent Development
Table 60. GlaxoSmithKline Plc Company Detail
Table 61. GlaxoSmithKline Plc Business Overview
Table 62. GlaxoSmithKline Plc Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 63. GlaxoSmithKline Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024) & (US$ Million)
Table 64. GlaxoSmithKline Plc Recent Development
Table 65. H. Lundbeck AS Company Detail
Table 66. H. Lundbeck AS Business Overview
Table 67. H. Lundbeck AS Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 68. H. Lundbeck AS Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024) & (US$ Million)
Table 69. H. Lundbeck AS Recent Development
Table 70. Pfizer Inc. Company Detail
Table 71. Pfizer Inc. Business Overview
Table 72. Pfizer Inc. Selective Serotonin Reuptake Inhibitors (SSRIs) Product
Table 73. Pfizer Inc. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024) & (US$ Million)
Table 74. Pfizer Inc. Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type: 2023 VS 2030
Figure 3. Citalopram (Celexa) Features
Figure 4. Escitalopram (Lexapro) Features
Figure 5. Fluoxetine (Prozac) Features
Figure 6. Paroxetine (Paxil, Pexeva) Features
Figure 7. Sertraline (Zoloft) Features
Figure 8. Vilazodone (Viibryd) Features
Figure 9. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application: 2023 VS 2030
Figure 11. Depression Case Studies
Figure 12. Anxiety and panic disorder Case Studies
Figure 13. Other mental conditions Case Studies
Figure 14. Selective Serotonin Reuptake Inhibitors (SSRIs) Report Years Considered
Figure 15. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region: 2023 VS 2030
Figure 18. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Players in 2023
Figure 19. Global Top Selective Serotonin Reuptake Inhibitors (SSRIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue in 2023
Figure 21. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2019-2030)
Figure 23. United States Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2019-2030)
Figure 27. Germany Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Region (2019-2030)
Figure 35. China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2019-2030)
Figure 43. Mexico Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Country (2019-2030)
Figure 47. Turkey Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Allergan Plc Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024)
Figure 50. Eli Lilly and Co. Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024)
Figure 51. GlaxoSmithKline Plc Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024)
Figure 52. H. Lundbeck AS Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024)
Figure 53. Pfizer Inc. Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed